User Reviews for Catapres-TTS

The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care.

Learn more about Catapres-TTS.

Reviews for Catapres-TTS to treat Bipolar Disorder

No reviews have yet been submitted. Be the first to review this drug.

Related Catapres-TTS Information

Availability Prescription only

CSA Schedule Not a controlled drug

Pregnancy Category Risk cannot be ruled out

Approval History Drug history at FDA

FDA Consumer Updates

More FDA Updates...

Related Pages

Manufacturer

Boehringer Ingelheim Pharmaceuticals, Inc

Drug Class

Antiadrenergic agents, centrally acting

Recently Approved

Zioptan
Zioptan (tafluprost ophthalmic solution) is a prostaglandin analog indicated for reducing elevated ...
Mitosol
Mitosol (mitomycin) is an antimetabolite indicated as an adjunct to ab externo glaucoma surgery.
Sklice
Sklice (ivermectin) Lotion is a pediculicide indicated for the topical treatment of head lice infestations in ...
Jentadueto
Jentadueto (linagliptin and metformin) is a dipeptidyl peptidase-4 (DPP-4) inhibitor and biguanide ...
Kalydeco
Kalydeco (ivacaftor) is a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator indicated ...

More...

Drug Images

Catapres-TTS-1 0.1 mg / 24 hour

View larger images

Get Updates by Email

Email me about Catapres-TTS:

Related News and Articles

Young Adults Who Quit Smoking Feel Better Quickly 10 February 2012
Young adults who quit smoking saw improvements in coughing and other respiratory symptoms within a few weeks, a new study indicates. It included 327 college...
Forest Laboratories, Inc. and Gedeon Richter Plc Announce Positive Phase III Results with the Investigational Antipsychotic Cariprazine in Patients with Acute Mania Associated with Bipolar I Disorder 8 February 2012
Feb 8, 2012 - Forest Laboratories, Inc. (NYSE: FRX) and Gedeon Richter Plc. today announced preliminary top-line results from a Phase III clinical trial of...
Quitting Smoking May Halve Risk of Oral Health Problems 7 February 2012
Adult smokers are twice as likely to develop oral health problems as those who have kicked the habit, researchers from the U.S. Centers for Disease Control and...
More Newborns Suffering Drug Withdrawal at Birth 30 January 2012
A dramatic rise in newborns experiencing drug withdrawal after being exposed in the womb poses challenges for clinicians on how to detox these tiny victims, a...
Positive Reinforcement May Help Patients Take Their Meds 27 January 2012
Positive reinforcement, such as receiving small, unexpected gifts and introducing upbeat thoughts into daily routines, seems to help patients with high blood...

Help and Support

Looking for answers? Ask a question or go join the Catapres-TTS support group to connect with others who have similar interests.

Did you find this page helpful? Yes No

Support

About Drugs.com

Your Privacy

Follow us on: Google+ Facebook Twitter

Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines & natural products. This material is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.

Data sources include Micromedex™ (updated Jan 27th, 2011), Cerner Multum™ (updated Jan 3rd, 2012), Wolters Kluwer™ (updated Jan 31st, 2012) and others.
To view content sources and attributions, refer to our editorial policy.

We comply with the HONcode standard for trustworthy health information.
Verify here

Terms of Use · Privacy Policy

Browse all medications A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Advanced Phonetic
Search:

User Reviews for Catapres-TTS

Reviews for Catapres-TTS to treat Bipolar Disorder

See also...

Related Catapres-TTS Information